38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bordetella pertussis antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Acellular Bordetella pertussis only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Rota rotavirus unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Hib Haemophilus influenzae type b unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
vaccin contenant seulement antigène du virus de la rougeole (produit médicinal)	Count of base of active ingredient	False	un	Inferred relationship	Some
Human papillomavirus 9 antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Live attenuated Measles morbillivirus antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Influenza virus antigen only vaccine product in nasal dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Inf influenza A virus subtype H1N1 unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Varicella-zoster live attenuated vaccine	Count of base of active ingredient	False	un	Inferred relationship	Some
Eptinezumab only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only eptinezumab (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ozanimod (as ozanimod hydrochloride) 230 microgram oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Ozanimod (as ozanimod hydrochloride) 230 microgram oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ozanimod (as ozanimod hydrochloride) 460 microgram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ozanimod (as ozanimod hydrochloride) 460 microgram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ozanimod (as ozanimod hydrochloride) 920 microgram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ozanimod (as ozanimod hydrochloride) 920 microgram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ozanimod only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only ozanimod (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Hib-HB Haemophilus influenzae de type b + hépatite B pédiatrique non spécifié	Count of base of active ingredient	False	un	Inferred relationship	Some
Sacituzumab govitecan only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Sacituzumab govitecan only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
HB hepatitis B unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Inactivated whole Japanese encephalitis virus antigen adsorbed only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Neisseria meningitidis serogroup A and C only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Men-ACYW-135 meningococcal A + C + Y + W-135 unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
LYM Lyme unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Human alphaherpesvirus 3 antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Hepatitis B surface antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only olaparib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Olaparib 150 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Olaparib 150 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely olaparib 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely olaparib 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Nevirapine 50 mg prolonged-release oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Nevirapine 50 mg prolonged-release oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Abacavir (as abacavir sulfate) 60 mg tablet for oral suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Abacavir (as abacavir sulfate) 60 mg tablet for oral suspension	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely efavirenz 600 milligram and lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely tenofovir disoproxil fumarate 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely tenofovir disoproxil fumarate 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Capmatinib only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only capmatinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Capmatinib 200 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Capmatinib 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Capmatinib 150 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Capmatinib 150 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only selpercatinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Selpercatinib only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selpercatinib 40 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selpercatinib 40 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Selpercatinib 80 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Selpercatinib 80 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only ripretinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ripretinib only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Inf influenza A virus subtype H1N1 unspecified	Count of active ingredient	False	un	Inferred relationship	Some
Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Atazanavir (as atazanavir sulfate) 300 mg and ritonavir 100 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pyrazinamide 400 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Pyrazinamide 400 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only flortaucipir (18-F) (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Flortaucipir (18-F) only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampin 150 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampin 150 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampin 150 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely methadone hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely methadone hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing only inebilizumab (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Inebilizumab only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely inebilizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely inebilizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Canakinumab only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Lurbinectedin only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Lurbinectedin 4 mg lyophilized powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Lurbinectedin 4 mg lyophilized powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lurbinectedin only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1

Start Previous Page 109 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core